Prime Healthcare ER Admit Scheme

What happened

Prime Healthcare Services operates a chain of for-profit hospitals across multiple states. Between roughly 2006 and 2014, Prime entered into medical-director agreements with the physicians who staffed the emergency departments at 14 of its hospitals. The contracts paid base directorship stipends plus "quality-and-leadership" bonuses calculated from a formula that included, among other variables, the percentage of ED patients admitted to inpatient status.

The structure created a direct financial incentive for ED medical directors to admit rather than treat-and-release. The inpatient-admission rate is one of the most-litigated quality measures in healthcare; appropriate-admission decisions hinge on clinical judgment, and tying compensation to the rate contaminates the judgment. Prime's admission rates exceeded regional benchmarks substantially — the alleged "uplift" averaged 60% above peer-hospital baselines — and the excess admissions translated directly into Medicare DRG payments.

A former Prime Healthcare physician filed a qui tam suit in 2011, supported by detailed admission-pattern analyses. The case settled for $65M in August 2018 with no admission of liability. CEO Prem Reddy individually paid $3.25M as part of the settlement — an unusual personal-liability outcome that signaled DOJ's willingness to pursue executives in Stark FCA cases.

What this means for your arrangements

Prime Healthcare extends Halifax to a quality-metric context. A "quality" bonus that includes any metric correlated with referral or admission volume fails the Stark exception's volume-or-value test, even when other quality components are legitimate. The presence of legitimate quality measures alongside referral-correlated measures does not redeem the structure.

The teachable subtlety is in benchmarking. Prime's admission rates were objectively high. Anomalous metrics relative to peer hospitals will be the first thing a DOJ investigator looks at; an arrangement that creates an anomaly is forensically visible long before any whistleblower files. Internal peer- benchmarking is itself a defensive practice.

How ArrowISE prevents this pattern

ArrowISE flags compensation arrangements whose bonus components include any volume-correlated metric — including admission rates, procedure volumes, and DRG mix — under the Schena-Shield volume_value_compensation pattern. The Defensibility Index drops sharply when this pattern is detected. The arrangement Risk tab surfaces the offending metric explicitly, so a reviewer can redesign the bonus formula at contracting time rather than discovering the issue during an audit response.